GLP-1 Drug Semaglutide Shows Weight-Loss-Independent Joint Repair in Osteoarthritis

1 min read
Source: ScienceAlert
GLP-1 Drug Semaglutide Shows Weight-Loss-Independent Joint Repair in Osteoarthritis
Photo: ScienceAlert
TL;DR

A new study indicates semaglutide may repair osteoarthritis damage by reprogramming cartilage-cell energy metabolism via the GLP-1R–AMPK–PFKFB3 axis, with mouse data showing protection beyond weight loss and a small human trial (HA + semaglutide) reporting reduced pain and thicker cartilage—suggesting a weight-loss–independent mechanism that requires further clinical validation.

Share this article

Want the full story? Read the original reporting

Read on ScienceAlert